Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122418765 | 12241876 | 5 | F | 201603 | 20160727 | 20160406 | 20160815 | EXP | US-GLAXOSMITHKLINE-US2016041013 | GLAXOSMITHKLINE | 80.93 | YR | F | Y | 0.00000 | 20160815 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122418765 | 12241876 | 1 | PS | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 1 PUFF(S), 1D | U | 5ZP1352 | 203975 | 1 | DF | INHALATION POWDER | QD | ||||
| 122418765 | 12241876 | 2 | SS | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 62.25/25MCG 1 PUFF(S), QD | U | R750340 | 203975 | 1 | DF | INHALATION POWDER | QD | ||||
| 122418765 | 12241876 | 3 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 2 PUFF(S), U | Y | 0 | 2 | DF | |||||||
| 122418765 | 12241876 | 4 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | UNK | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122418765 | 12241876 | 1 | Dyspnoea |
| 122418765 | 12241876 | 2 | Chronic obstructive pulmonary disease |
| 122418765 | 12241876 | 3 | Chronic obstructive pulmonary disease |
| 122418765 | 12241876 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122418765 | 12241876 | OT |
| 122418765 | 12241876 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122418765 | 12241876 | Accidental exposure to product | |
| 122418765 | 12241876 | Amnesia | |
| 122418765 | 12241876 | Asthma | |
| 122418765 | 12241876 | Chest pain | |
| 122418765 | 12241876 | Choking sensation | |
| 122418765 | 12241876 | Condition aggravated | |
| 122418765 | 12241876 | Cough | |
| 122418765 | 12241876 | Drug ineffective | |
| 122418765 | 12241876 | Drug interaction | |
| 122418765 | 12241876 | Dry mouth | |
| 122418765 | 12241876 | Dyspepsia | |
| 122418765 | 12241876 | Dyspnoea | |
| 122418765 | 12241876 | Headache | |
| 122418765 | 12241876 | Heart rate irregular | |
| 122418765 | 12241876 | Hypersensitivity | |
| 122418765 | 12241876 | Loss of consciousness | |
| 122418765 | 12241876 | Multiple allergies | |
| 122418765 | 12241876 | Nasal congestion | |
| 122418765 | 12241876 | Oesophageal pain | |
| 122418765 | 12241876 | Oropharyngeal pain | |
| 122418765 | 12241876 | Overdose | |
| 122418765 | 12241876 | Pharyngeal disorder | |
| 122418765 | 12241876 | Therapeutic response unexpected | |
| 122418765 | 12241876 | Underdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122418765 | 12241876 | 1 | 20160301 | 0 |